$BC
BRUNSWICK CORP Stock $bc

$bc Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000001493024000103 Filed on May 02, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$1.444B	$1.365B
YoY Change	-17.19%
Cost Of Revenue	$1.053B	$991.4M
YoY Change	-14.95%
Gross Profit	$391.0M	$373.6M
YoY Change	-22.67%
Gross Profit Margin	27.08%	27.37%
Selling, General & Admin	$181.8M	$203.7M
YoY Change	-13.96%
% of Gross Profit	46.5%	54.52%
Research & Development	$43.00M	$45.80M
YoY Change	-11.7%
% of Gross Profit	11.0%	12.26%
Depreciation & Amortization	$70.40M	$69.40M
YoY Change	8.81%
% of Gross Profit	18.01%	18.58%
Operating Expenses	$224.8M	$249.5M
YoY Change	-13.54%
Operating Profit	$166.2M	$124.1M
YoY Change	-29.61%
Interest Expense	-$25.00M	-$23.60M
YoY Change	-188.65%
% of Operating Profit	-15.04%	-19.02%
Other Income/Expense, Net	-$800.0K	$0.00
YoY Change	-11.11%
Pretax Income	$132.5M	$87.00M
YoY Change	-37.32%
Income Tax	$27.70M	$18.60M
% Of Pretax Income	20.91%	21.38%
Net Earnings	$100.0M	$68.00M
YoY Change	-10.95%
Net Earnings / Revenue	6.93%	4.98%
Basic Earnings Per Share	$1.48	$0.99
Diluted Earnings Per Share	$1.47	$1.00
COMMON SHARES
Basic Shares Outstanding	67.57M shares	68.17M shares
Diluted Shares Outstanding	67.60M shares	68.50M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$577.0M	$549.2M
YoY Change	48.48%
Cash & Equivalents	$494.5M	$548.4M
Short-Term Investments	$82.50M	$800.0K
Other Short-Term Assets	$96.90M	$86.20M
YoY Change	12.94%
Inventory	$1.524B	$1.555B
Prepaid Expenses
Receivables	$530.0M	$616.8M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.728B	$2.807B
YoY Change	1.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.454B	$1.468B
YoY Change	12.42%
Goodwill	$1.024B	$1.026B
YoY Change	5.14%
Intangibles	$948.1M	$964.3M
YoY Change	-4.46%
Long-Term Investments	$37.50M	$41.40M
YoY Change	-39.02%
Other Assets	$203.8M	$201.6M
YoY Change	-91.2%
Total Long-Term Assets	$3.668B	$3.702B
YoY Change	1.59%
TOTAL ASSETS
Total Short-Term Assets	$2.728B	$2.807B
Total Long-Term Assets	$3.668B	$3.702B
Total Assets	$6.396B	$6.509B
YoY Change	1.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$447.9M	$513.8M
YoY Change	-24.6%
Accrued Expenses	$705.5M	$704.6M
YoY Change	-6.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$454.7M	$455.4M
YoY Change	406.35%
Total Short-Term Liabilities	$1.608B	$1.674B
YoY Change	11.78%
LONG-TERM LIABILITIES
Long-Term Debt	$2.372B	$2.372B
YoY Change	-1.99%
Other Long-Term Liabilities	$401.6M	$413.4M
YoY Change	100.8%
Total Long-Term Liabilities	$2.774B	$2.785B
YoY Change	-0.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.608B	$1.674B
Total Long-Term Liabilities	$2.774B	$2.785B
Total Liabilities	$4.382B	$4.459B
YoY Change	3.69%
SHAREHOLDERS EQUITY
Retained Earnings	$3.708B	$3.636B
YoY Change	9.96%
Common Stock	$466.1M	$460.3M
YoY Change	2.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.118B	$2.011B
YoY Change	21.95%
Treasury Stock Shares
Shareholders Equity	$2.014B	$2.050B
YoY Change
Total Liabilities & Shareholders Equity	$6.396B	$6.509B
YoY Change	1.7%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$100.0M	$68.00M
YoY Change	-10.95%
Depreciation, Depletion And Amortization	$70.40M	$69.40M
YoY Change	8.81%
Cash From Operating Activities	$211.0M	-$153.4M
YoY Change	-1435.44%
INVESTING ACTIVITIES
Capital Expenditures	$47.10M	$54.00M
YoY Change	-49.63%
Acquisitions
YoY Change
Other Investing Activities	-$73.50M	-$1.400M
YoY Change
Cash From Investing Activities	-$120.6M	-$55.40M
YoY Change	27.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$600.0K
YoY Change
Cash From Financing Activities	-136.9M	294.1M
YoY Change	35.68%
NET CHANGE
Cash From Operating Activities	211.0M	-153.4M
Cash From Investing Activities	-120.6M	-55.40M
Cash From Financing Activities	-136.9M	294.1M
Net Change In Cash	-46.50M	85.30M
YoY Change	-77.81%
FREE CASH FLOW
Cash From Operating Activities	$211.0M	-$153.4M
Capital Expenditures	$47.10M	$54.00M
Free Cash Flow	$163.9M	-$207.4M
YoY Change	-249.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.75
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.75
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102538000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102538000	shares
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2023Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	991400000	usd
CY2023Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1238000000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	203700000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	211300000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45800000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48700000	usd
CY2024Q1	bcorp	Restructuring Exitand Impairment Charges RestructuringExitandImpairmentCharges	13500000	usd
CY2023Q2	bcorp	Restructuring Exitand Impairment Charges RestructuringExitandImpairmentCharges	9500000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	110600000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	236100000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2500000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2200000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-900000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	113100000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	237400000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	28600000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	28200000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2500000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2200000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	87000000.0	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	211400000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18600000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000000.0	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	68400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	112400000	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-400000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-100000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68000000.0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	112300000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.00
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.57
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.57
CY2024Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.00
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.56
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	68300000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71500000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68500000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71800000	shares
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	57500000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	115900000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	548400000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	467800000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	387800000	usd
CY2024Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	11100000	usd
CY2023Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	11100000	usd
CY2023Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	11100000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	800000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	800000	usd
CY2023Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	800000	usd
CY2024Q1	bcorp	Cash Cash Equivalents Restricted Cash And Short Term Investments CashCashEquivalentsRestrictedCashAndShortTermInvestments	560300000	usd
CY2023Q4	bcorp	Cash Cash Equivalents Restricted Cash And Short Term Investments CashCashEquivalentsRestrictedCashAndShortTermInvestments	479700000	usd
CY2023Q2	bcorp	Cash Cash Equivalents Restricted Cash And Short Term Investments CashCashEquivalentsRestrictedCashAndShortTermInvestments	399700000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	11200000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10800000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10600000	usd
CY2024Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	616800000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	493200000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	698000000.0	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1028100000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	932000000.0	usd
CY2023Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	858600000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	166000000.0	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	181600000	usd
CY2023Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	218400000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	360900000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	363200000	usd
CY2023Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	429000000.0	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	1555000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1476800000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1506000000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	75100000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	60000000.0	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	74700000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	2807200000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2509700000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2678400000	usd
CY2024Q1	us-gaap	Land Land	44000000.0	usd
CY2023Q4	us-gaap	Land Land	44100000	usd
CY2023Q2	us-gaap	Land Land	42800000	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	621700000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	619700000	usd
CY2023Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	582700000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1560500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1551500000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	1506700000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2226200000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2215300000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2132200000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1153800000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1135500000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1074200000	usd
CY2024Q1	bcorp	Land Buildings And Improvements And Equipment Net LandBuildingsAndImprovementsAndEquipmentNet	1072400000	usd
CY2023Q4	bcorp	Land Buildings And Improvements And Equipment Net LandBuildingsAndImprovementsAndEquipmentNet	1079800000	usd
CY2023Q2	bcorp	Land Buildings And Improvements And Equipment Net LandBuildingsAndImprovementsAndEquipmentNet	1058000000	usd
CY2024Q1	bcorp	Unamortized Product Tooling Costs UnamortizedProductToolingCosts	236600000	usd
CY2023Q4	bcorp	Unamortized Product Tooling Costs UnamortizedProductToolingCosts	236000000.0	usd
CY2023Q2	bcorp	Unamortized Product Tooling Costs UnamortizedProductToolingCosts	235500000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1309000000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1315800000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1293500000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1026300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1030700000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	974000000.0	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	964300000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	978000000.0	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	992400000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	185500000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	186800000	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	148300000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	158900000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	152200000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	122600000	usd
CY2024Q1	us-gaap	Equity Method Investments EquityMethodInvestments	41400000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	38700000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	61500000	usd
CY2024Q1	bcorp	Other Long Term Assets OtherLongTermAssets	16100000	usd
CY2023Q4	bcorp	Other Long Term Assets OtherLongTermAssets	18600000	usd
CY2023Q2	bcorp	Other Long Term Assets OtherLongTermAssets	17900000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2392500000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2405000000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2316700000	usd
CY2024Q1	us-gaap	Assets Assets	6508700000	usd
CY2023Q4	us-gaap	Assets Assets	6230500000	usd
CY2023Q2	us-gaap	Assets Assets	6288600000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	455400000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	454700000	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	89800000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	513800000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	558000000.0	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	594000000.0	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	704600000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	739400000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	754800000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1673800000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1752100000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1438600000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2371900000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1975700000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2420500000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	140700000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	133900000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	106300000	usd
CY2024Q1	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	49700000	usd
CY2023Q4	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	52500000	usd
CY2023Q2	us-gaap	Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent	48300000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	12100000	usd
CY2023Q4	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	12400000	usd
CY2023Q2	us-gaap	Deferred Income Taxes And Other Tax Liabilities Noncurrent DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent	12400000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	210900000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	216500000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	200000000.0	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2785300000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2391000000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2787500000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.75
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102538000	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67689000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68227000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70891000	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	76900000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	76900000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	76900000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	383400000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	392000000.0	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	376000000.0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3636300000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3596900000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3372300000	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	34849000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	34311000	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	31647000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	2010800000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1952700000	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1736800000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36200000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25700000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25900000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2049600000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2087400000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2062500000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6508700000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6230500000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6288600000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68000000.0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	112300000	usd
CY2024Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-400000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-100000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	68400000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	112400000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	69400000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64700000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6100000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	5900000	usd
CY2024Q1	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-300000	usd
CY2023Q2	us-gaap	Pension Expense Reversal Of Expense Noncash PensionExpenseReversalOfExpenseNoncash	-600000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-500000	usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1200000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1900000	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2200000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets And Liabilities Net IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	301200000	usd
CY2023Q2	us-gaap	Increase Decrease In Other Current Assets And Liabilities Net IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet	269700000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2100000	usd
CY2023Q2	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2500000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	200000	usd
CY2023Q2	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	78400000	usd
CY2024Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	4800000	usd
CY2023Q2	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-11500000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-148100000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-14500000	usd
CY2024Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5300000	usd
CY2023Q2	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1300000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-153400000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15800000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54000000.0	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	93500000	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3800000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	3000000.0	usd
CY2023Q2	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	7600000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	700000	usd
CY2023Q2	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2300000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2700000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55400000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94600000	usd
CY2024Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1100000	usd
CY2023Q2	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1400000	usd
CY2024Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	900000	usd
CY2023Q2	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	200000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	396900000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	600000	usd
CY2023Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	600000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	63600000	usd
CY2023Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	60000000.0	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28600000	usd
CY2023Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	28500000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9200000	usd
CY2023Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13000000.0	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000.0	usd
CY2023Q2	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	294100000	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-100900000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4700000	usd
CY2023Q2	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1700000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	80600000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-209600000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	478900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	608500000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	559500000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	398900000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11100000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11100000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	548400000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	387800000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2087400000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68000000.0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10500000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.42
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28600000	usd
CY2024Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	2600000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	64100000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	2049600000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2042300000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	112300000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3600000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2023Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	28500000	usd
CY2023Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	6800000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	60400000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2062500000	usd
CY2024Q1	us-gaap	Fiscal Period FiscalPeriod	<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains its financial records on the basis of a fiscal year ending on December 31, with the fiscal quarters spanning approximately thirteen weeks. The first quarter ends on the Saturday closest to the end of the first thirteen-week period. The second and third quarters are thirteen weeks in duration and the fourth quarter is the remainder of the year. The first quarter of fiscal year 2024 ended on March 30, 2024 and the first quarter of fiscal year 2023 ended on April 1, 2023.</span></div>
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1365000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1743600000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1365000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1743600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	187100000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20500000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	198400000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	189800000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	48600000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	52000000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	89200000	usd
CY2024Q1	bcorp	Restructuring Exitand Impairment Charges RestructuringExitandImpairmentCharges	13500000	usd
CY2024Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	12400000	usd
CY2024Q1	us-gaap	Restructuring Reserve RestructuringReserve	9900000	usd
CY2023Q2	bcorp	Restructuring Exitand Impairment Charges RestructuringExitandImpairmentCharges	9500000	usd
CY2023Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	2500000	usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	9900000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	146700000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	23500000	usd
CY2024Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2659500000	usd
CY2023Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2228200000	usd
CY2023Q2	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2257400000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2859100000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2458700000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2541200000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	157600000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	19400000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	18400000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	25200000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	-100000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Preexisting Increase Decrease StandardProductWarrantyAccrualPreexistingIncreaseDecrease	300000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-800000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual Foreign Currency Translation Gain Loss StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss	300000	usd
CY2024Q1	bcorp	Standard Product Warranty Accrual Other Increase Decrease StandardProductWarrantyAccrualOtherIncreaseDecrease	-1700000	usd
CY2023Q2	bcorp	Standard Product Warranty Accrual Other Increase Decrease StandardProductWarrantyAccrualOtherIncreaseDecrease	1300000	usd
CY2024Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	149900000	usd
CY2023Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	154400000	usd
CY2023Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	127200000	usd
CY2022Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	112500000	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual Warranties Issued ExtendedProductWarrantyAccrualWarrantiesIssued	9600000	usd
CY2023Q2	us-gaap	Extended Product Warranty Accrual Warranties Issued ExtendedProductWarrantyAccrualWarrantiesIssued	8900000	usd
CY2024Q1	bcorp	Extended Product Warranty Accrual Decrease For Revenue Recognized ExtendedProductWarrantyAccrualDecreaseForRevenueRecognized	7300000	usd
CY2023Q2	bcorp	Extended Product Warranty Accrual Decrease For Revenue Recognized ExtendedProductWarrantyAccrualDecreaseForRevenueRecognized	6300000	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual Foreign Currency Translation Gain Loss ExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	-200000	usd
CY2023Q2	us-gaap	Extended Product Warranty Accrual Foreign Currency Translation Gain Loss ExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss	0	usd
CY2024Q1	bcorp	Extended Product Warranty Accrual Other Increase Decrease ExtendedProductWarrantyAccrualOtherIncreaseDecrease	-100000	usd
CY2023Q2	bcorp	Extended Product Warranty Accrual Other Increase Decrease ExtendedProductWarrantyAccrualOtherIncreaseDecrease	-100000	usd
CY2024Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	129200000	usd
CY2023Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	115000000.0	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1030700000	usd
CY2024Q1	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-4400000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	1026300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	967600000	usd
CY2023Q2	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	6400000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	974000000.0	usd
CY2023Q3	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	4500000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1481400000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	517100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1477500000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	499500000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1442400000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	450000000.0	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17900000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16600000	usd
CY2024Q1	us-gaap	Revenues Revenues	1365000000	usd
CY2023Q2	us-gaap	Revenues Revenues	1743600000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	110600000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	236100000	usd
CY2024Q1	us-gaap	Assets Assets	6508700000	usd
CY2023Q4	us-gaap	Assets Assets	6230500000	usd
CY2023Q2	us-gaap	Assets Assets	6288600000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	68000000.0	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	112300000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19600000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6300000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	100000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-100000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	100000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	9300000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-2800000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-10500000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3600000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	57500000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	115900000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25700000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-9600000	usd
CY2024Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	900000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-10500000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-36200000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	-3000000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	3700000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	400000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-29500000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	8400000	usd
CY2023Q2	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	4800000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3600000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25900000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax	100000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	1000000.0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	1900000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.468
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	454700000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1975700000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2430400000	usd
CY2024Q1	bcorp	Proceeds From Issuance Of Long Term Debt Current ProceedsFromIssuanceOfLongTermDebtCurrent	1100000	usd
CY2024Q1	bcorp	Proceeds From Issuance Of Long Term Debt Excluding Current Maturities ProceedsFromIssuanceOfLongTermDebtExcludingCurrentMaturities	396900000	usd
CY2024Q1	bcorp	Proceeds From Issuance Of Long Term Debt Current And Long Term ProceedsFromIssuanceOfLongTermDebtCurrentAndLongTerm	398000000.0	usd
CY2024Q1	bcorp	Repayments Of Long Term Debt Current RepaymentsOfLongTermDebtCurrent	1500000	usd
CY2024Q1	bcorp	Repayments Of Long Term Debt Excluding Current Maturities RepaymentsOfLongTermDebtExcludingCurrentMaturities	0	usd
CY2024Q1	bcorp	Repayments Of Long Term Debt Current And Long Term RepaymentsOfLongTermDebtCurrentAndLongTerm	1500000	usd
CY2024Q1	us-gaap	Short Term Debt Refinanced Amount ShortTermDebtRefinancedAmount	600000	usd
CY2024Q1	us-gaap	Short Term Debt Refinanced Amount ShortTermDebtRefinancedAmount	600000	usd
CY2024Q1	bcorp	Reclassification Of Total Debt ReclassificationOfTotalDebt	0	usd
CY2024Q1	bcorp	Other Debt Activity Current OtherDebtActivityCurrent	500000	usd
CY2024Q1	bcorp	Other Debt Activity Excluding Current Maturities OtherDebtActivityExcludingCurrentMaturities	100000	usd
CY2024Q1	bcorp	Other Debt Activity Current And Long Term OtherDebtActivityCurrentAndLongTerm	400000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	455400000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2371900000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2827300000	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	396900000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Commercial Paper ProceedsFromIssuanceOfCommercialPaper	425000000	usd
CY2024Q1	bcorp	Commercial Paper Maximum Amount Utilized CommercialPaperMaximumAmountUtilized	225000000	usd
CY2023Q2	us-gaap	Proceeds From Issuance Of Commercial Paper ProceedsFromIssuanceOfCommercialPaper	85000000	usd
CY2023Q2	bcorp	Commercial Paper Maximum Amount Utilized CommercialPaperMaximumAmountUtilized	85000000	usd
CY2024Q1	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	14800000	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	11600000	usd
CY2023Q2	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	19900000	usd

Files In Submission

Name	View Source	Status
0000014930-24-000103-index-headers.html	Edgar Link	pending
0000014930-24-000103-index.html	Edgar Link	pending
0000014930-24-000103.txt	Edgar Link	pending
0000014930-24-000103-xbrl.zip	Edgar Link	pending
bc20240330ex311.htm	Edgar Link	pending
bc20240330ex312.htm	Edgar Link	pending
bc20240330ex321.htm	Edgar Link	pending
bc20240330ex322.htm	Edgar Link	pending
bcorp-20240330.htm	Edgar Link	pending
bcorp-20240330.xsd	Edgar Link	pending
bcorp-20240330_g1.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
bcorp-20240330_cal.xml	Edgar Link	unprocessable
bcorp-20240330_def.xml	Edgar Link	unprocessable
bcorp-20240330_lab.xml	Edgar Link	unprocessable
bcorp-20240330_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bcorp-20240330_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BC
BRUNSWICK CORP Stock $bc

2024 Q2 Form 10-Q Financial Statement

#000001493024000103 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BC BRUNSWICK CORP Stock $bc

2024 Q2 Form 10-Q Financial Statement

#000001493024000103 Filed on May 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BC
BRUNSWICK CORP Stock $bc